(firstQuint)The Effects of an Infant Formula Containing Probiotic CECT7210 on Gastrointestinal Health.

 This a multicenter, controlled, randomized, prospective, parallel, double-blinded study to evaluate the effect of an infant formula containing a new probiotic, Bifidobacterium longum biovar infantis CECT7210, on the incidence of diarrhea in healthy infants born at term.

 Infants will be randomized to take an standard infant formula or the infant formula with the probiotic CECT7210 during 12 weeks.

.

 The Effects of an Infant Formula Containing Probiotic CECT7210 on Gastrointestinal Health@highlight

The purpose of this study is to determine whether an infant formula supplemented with a new probiotic CECT7210, is effective in reducing the incidence of infections, specially the gastrointestinal ones.

